Lifibrol increases hepatic cholesterol 7α-hydroxylase activity in sprague-dawley rats.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 439, doi. 10.1002/ddr.430330407
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 1994 AND VI 33 AND IP 4
Results: 11
1
2
Selective fluorescent ligands for pharmacological receptors.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 373, doi. 10.1002/ddr.430330402
- By:
- Publication type:
- Article
3
New 1,4-benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 429, doi. 10.1002/ddr.430330406
- By:
- Publication type:
- Article
4
Masthead.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. fmi, doi. 10.1002/ddr.430330401
- Publication type:
- Article
5
Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin-converting enzyme inhibitor with an angiotensin II receptor antagonist.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 422, doi. 10.1002/ddr.430330405
- By:
- Publication type:
- Article
6
Effects of GS 386, a novel dihydroisoquinoline compound, on rabbit atrial myocytes and rat aorta.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 454, doi. 10.1002/ddr.430330409
- By:
- Publication type:
- Article
7
The RBI handbook of receptor classification. John W. Kebabian and John L. Neumeyer, eds. Research Biochemicals International, Natick, MA, 1994, 122 pages, $25.00.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 461, doi. 10.1002/ddr.430330411
- By:
- Publication type:
- Article
8
Dopamine uptake inhibitory activity of novel tryptamine 5-HT<sub>1</sub> receptor ligands.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 413, doi. 10.1002/ddr.430330404
- By:
- Publication type:
- Article
9
Histamine receptor-subtype affinities, selectivities, and potencies of emedastine, a novel H<sub>1</sub>-selective antagonist, and other ocularly employed antihistamines.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 448, doi. 10.1002/ddr.430330408
- By:
- Publication type:
- Article
10
The year's drug news. Therapeutic targets 1994. J.R. Prous, Prous Science Publishers, Barcelona, Spain, 1994, xxiv + 549 pages, $500.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 460, doi. 10.1002/ddr.430330410
- By:
- Publication type:
- Article
11
In vivo pharmacological profile of 9-hydroxyrisperidone, the major metabolite of the novel antipsychotic risperidone.
- Published in:
- Drug Development Research, 1994, v. 33, n. 4, p. 399, doi. 10.1002/ddr.430330403
- By:
- Publication type:
- Article